Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Opioid receptors are a group of inhibitory G protein-coupled receptors (GPCRs) that mediate the effects of endogenous and exogenous opioids. These receptors play a central role in pain modulation, reward, addiction, and various physiological processes. There are three main classical opioid receptor subtypes: Mu (μ), Delta (δ), and Kappa (κ), as well as the Nociceptin/orphanin FQ peptide (NOP) receptor. Activation results in decreased neuronal excitability and reduced neurotransmitter release.
Agonist binding induces conformational change, activating G proteins. Gαi/o subunit inhibits adenylyl cyclase, reducing cAMP levels, and modulates ion channels, leading to decreased neuronal excitability and reduced neurotransmitter release.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opioid Receptor (OR).